Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 16 EP applications Susanna Clare Hopley Price has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12707343

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

IPC classification:
A61K 31/4985, A61P 19/02, A61P 29/00, A61P 35/00, A61P 37/06, C07D 471/04, C07D 519/00
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707342

PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)

IPC classification:
A61K 31/47, A61P 37/00, C07D 401/12, C07D 403/12
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13836616

AMINO-QUINOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/47, C07D 215/42
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13837571

PRODRUGS OF AMINO QUINAZOLINE KINASE INHIBITOR

IPC classification:
A61K 31/535
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13763100

TREATMENT FOR RHEUMATOID ARTHRITIS

IPC classification:
A61K 39/395, A61P 29/00, C07K 16/24
Applicant:
MorphoSys AG
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13798807

THIENO[3,2-C]PYRIDIN-4(5H)-ONES AS BET INHIBITORS

IPC classification:
A61K 31/44, C07D 495/04
Applicant:
GlaxoSmithKline LLC
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
PATENT GRANTED
EP14705891

HETEROCYCLIC AMIDES AS KINASE INHIBITORS

IPC classification:
A61K 31/55, A61P 17/06, A61P 25/28, A61P 29/00, A61P 37/00, C07D 267/14, C07D 281/10, C07D 403/12, C07D 403/14, C07D 409/12, C07D 413/12, C07D 413/14, C07D 417/12, C07D 487/04, C07D 498/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14708681

QUINAZOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/505, C07D 403/12, C07D 405/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
The patent has been granted
EP14713394

2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4375, A61K 31/4706, A61K 31/4709, C07D 215/227, C07D 215/44, C07D 215/46, C07D 215/48, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/14, C07D 409/12, C07D 409/14, C07D 413/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14709932

FUROPYRIDINES AS BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/4355, A61K 31/5025, A61P 29/00, C07D 491/048
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
The patent has been granted
EP15194091

OSTEOARTHRITIS TREATMENT

IPC classification:
A61K 39/395, A61P 19/02, C07K 16/28
Applicant:
University of Melbourne
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11719781

7-(1H-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS

IPC classification:
A61K 31/4462, A61P 19/02, C07D 471/04
Applicant:
Glaxo Group Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11778419

AMINO-QUINOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/47, A61P 37/00, C07D 215/44, C07D 401/12, C07D 405/12, C07D 405/14, C07D 411/12, C07D 413/12, C07D 417/12, C07D 417/14
Applicant:
Glaxo Group Limited
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11816959

QUINOLYL AMINES AS KINASE INHIBITORS

IPC classification:
A61K 31/4706, A61P 19/00, C07D 401/12, C07D 405/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16162171

ANTI-GM-CSF ANTIBODIES AND USES THEREFOR

IPC classification:
A61K 39/00, C07K 16/24
Applicant:
MorphoSys AG
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16704713

CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROBENZO[B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE

IPC classification:
C07D 413/12
Agent:
Susanna Clare Hopley Price, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature